US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

OPTIMI HEALTH CORP.

4.71

-0.2100-4.27%

Volume:9K

Turnover:45.37K

Market Cap:26.50M

PE:-7.05

High:4.89

Open:4.89

Low:4.70

Close:4.92

52wk High:8.84

52wk Low:3.12

Shares:5.63M

Float Shares:2.50M

Volume Ratio:0.67

T/O Rate:0.38%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.6680

EPS(LYR):-0.2791

ROE:-88.70%

ROA:-20.28%

PB:10.56

PE(LYR):-16.87

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Optimi Health completes psilocybin export to Australia

Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression

Optimi launches standardized microdose psilocybin products for clinical research

Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/OPTH"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OPTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OPTH\",,,,,undefined,":{"symbol":"OPTH","market":"US","secType":"STK","nameCN":"OPTIMI HEALTH CORP.","latestPrice":4.71,"timestamp":1785258966378,"preClose":4.92,"halted":0,"volume":9454,"delay":0,"changeRate":-0.04268292682926829,"floatShares":2500000,"shares":5625900,"eps":-0.668,"marketStatus":"Trading","change":-0.21,"latestTime":"07-28 13:18:45 EDT","open":4.885,"high":4.885,"low":4.7,"amount":45369.140944000006,"amplitude":0.037602,"askPrice":4.79,"askSize":17,"bidPrice":4.7,"bidSize":96,"shortable":3,"etf":0,"ttmEps":-0.668,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1785268800000},"marketStatusCode":2,"adr":0,"listingDate":1779336000000,"exchange":"NASDAQ","adjPreClose":4.92,"postHourTrading":{"tag":"盘后","latestPrice":4.92,"preClose":4.92,"latestTime":"19:34 EDT","volume":13,"amount":63.69,"timestamp":1785195250598,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.674889},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OPTH\",,,,,undefined,":{"symbol":"OPTH","floatShares":2500000,"roa":"-20.28%","roe":"-88.70%","lyrEps":-0.27912,"volumeRatio":0.674889,"shares":5625900,"dividePrice":0,"high":4.885,"amplitude":0.037602,"preClose":4.92,"low":4.7,"week52Low":3.12,"pbRate":"10.56","psRate":"161.09","week52High":8.838,"institutionHeld":0,"latestPrice":4.71,"committee":0.699115,"eps":-0.668,"divideRate":0,"volume":9454,"delay":0,"ttmEps":-0.668,"open":4.885,"prevYearClose":6.852,"prevWeekClose":4.68,"prevMonthClose":5.09,"prevQuarterClose":5.09,"fiveDayClose":4.75,"twentyDayClose":4.45,"sixtyDayClose":8.1048},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OPTH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-20","symbol":"OPTH","defaultRemindTime":1779283800000,"type":"split","dateTimestamp":1779249600000,"forFactor":30,"toFactor":1,"ratio":30}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OPTH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OPTH\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OPTH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OPTH","date":"2026-07-24","current":-7.365269,"percent":0.511628,"low":-11.793672,"twenty":-8.309934,"median":-6.977012,"eighty":-6.49591,"high":-5.935667,"avg":-7.690688,"sd":1.767103,"marketCap":26627647.53},"quantilePoints":[{"date":"2026-05-22","current":-11.007427,"twenty":-11.411781,"median":-11.260148,"eighty":-11.108516,"marketCap":31992926.41},{"date":"2026-05-29","current":-10.824906,"twenty":-11.51287,"median":-11.084647,"eighty":-10.895107,"marketCap":31420041.14},{"date":"2026-06-05","current":-8.174559,"twenty":-11.51287,"median":-11.007427,"eighty":-8.434895,"marketCap":31768506.5},{"date":"2026-06-12","current":-5.935667,"twenty":-11.161868,"median":-9.6299,"eighty":-7.029079,"marketCap":22898412.63},{"date":"2026-06-18","current":-6.352205,"twenty":-11.105708,"median":-8.200592,"eighty":-6.747916,"marketCap":24280961.81},{"date":"2026-06-26","current":-6.039801,"twenty":-11.024275,"median":-7.39355,"eighty":-6.143936,"marketCap":22991167.17},{"date":"2026-07-02","current":-7.705953,"twenty":-10.940035,"median":-7.39355,"eighty":-6.175176,"marketCap":29347825.96},{"date":"2026-07-10","current":-6.85205,"twenty":-10.852986,"median":-7.13842,"eighty":-6.289724,"marketCap":26129662.18},{"date":"2026-07-17","current":-7.268589,"twenty":-9.390899,"median":-7.029079,"eighty":-6.289724,"marketCap":27971005.98},{"date":"2026-07-24","current":-6.945772,"twenty":-8.309934,"median":-6.977012,"eighty":-6.49591,"marketCap":26627647.53}],"updateTime":1785227932509},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OPTH\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2647303424","title":"Optimi Health completes psilocybin export to Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2647303424","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647303424?lang=en_us&edition=fundamental","pubTime":"2026-06-29 23:20","pubTimestamp":1782746418,"startTime":"0","endTime":"0","summary":"Optimi Health (OPTH) announced the completion of its latest export of 5mg psilocybin finished drug product to Australia, marking its third commerci...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/optimi-health-completes-psilocybin-export-to-australia-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/optimi-health-completes-psilocybin-export-to-australia-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647374792","title":"Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2647374792","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647374792?lang=en_us&edition=fundamental","pubTime":"2026-06-29 21:00","pubTimestamp":1782738000,"startTime":"0","endTime":"0","summary":"Optimi’s 5mg psilocybin capsules are prescribed in Australia for treatment-resistant depression.The export marks Optimi’s third commercial shipment since launching the 5mg psilocybin capsules in Septe","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/29/3318985/0/en/Optimi-Health-Completes-Psilocybin-Export-to-Australia-for-Patients-With-Treatment-Resistant-Depression.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644769468","title":"Optimi launches standardized microdose psilocybin products for clinical research","url":"https://stock-news.laohu8.com/highlight/detail?id=2644769468","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644769468?lang=en_us&edition=fundamental","pubTime":"2026-06-17 00:41","pubTimestamp":1781628061,"startTime":"0","endTime":"0","summary":"Optimi Health (OPTH) announced it has completed production of two microdose psilocybin finished drug products, formulated at 1 mg and 2 mg dosages....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/optimi-launches-standardized-microdose-psilocybin-products-for-clinical-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/optimi-launches-standardized-microdose-psilocybin-products-for-clinical-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642429206","title":"Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2642429206","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642429206?lang=en_us&edition=fundamental","pubTime":"2026-06-10 21:15","pubTimestamp":1781097300,"startTime":"0","endTime":"0","summary":"The shipment of naturally derived psilocybin, comprising both biomass and 5mg capsules, supports a planned Phase 2 clinical trial in the United Kingdom and was completed under export authorization fro","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/10/3309788/0/en/Optimi-Health-Completes-First-Export-of-Psilocybin-to-the-United-Kingdom-for-Phase-2-Clinical-Trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UBCP","BK4535","API","OPTH","BK4503","BK4551","BK4023","BK4211"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/OPTH\",params:#limit:6,delay:false,,,undefined,":[]}}